387
Views
4
CrossRef citations to date
0
Altmetric
Review

Transdermal delivery of glyceryl trinitrate: clinical applications in acute stroke

, &
Pages 297-303 | Received 20 Nov 2019, Accepted 13 Jan 2020, Published online: 23 Jan 2020

References

  • Bath PMW, Hassall DG, Gladwin A-M, et al. Nitric oxide and prostacyclin. Divergence of inhibitory effects on monocyte chemotaxis and adhesion to endothelium in vitro. Arteriosclerosis Thrombosis. 1991;11:254–260.
  • Radomski MW, Palmer RMJ, Moncada S. Endogenous nitric oxide inhibits human platelet adhesion to vascular endothelium. Lancet. 1987;ii:1057–1058.
  • Radomski MW, Palmer RMJ, Moncada S. The anti-aggregating properties of vascular endothelium: interactions between prostacyclin and nitric oxide. Br J Pharmacol. 1987;92:639–646.
  • Murad F, Waldman S, Monlina C, et al. Regulation and role of guanylate cyclase-cyclic GMP in vascular relaxation. Prog Clin Biol Res. 1987;249:65–76.
  • Garthwaite J, Charles SL, Chess-Williams R. Endothelium derived relaxing factor on activation of NMDA receptors suggests role as intercellular messenger in the brain. Nature. 1988;336:385–388.
  • Dawson TM, Snyder SH. Gases as biological messengers: nitric oxide and carbon monoxide in the brain. J Neurosci. 1994;14:5147–5159.
  • Tanaka K. Is nitric oxide really important for regulation of the cerebral circulation? Yes or no? Keio J Med. 1996;45:14–27.
  • White RP, Vallance P, Markus HS. Effect of inhibition of nitric oxide synthase on dynamic cerebral autoregulation in humans. Clin Sci. 2000;99:555–560.
  • Lavi S, Egbarya R, Lavi R, et al. Role of nitirc oxide in the regulation of cerebral blood flow in humans. Chemoregulation versus mechanoregulation. Circulation. 2003 April 15;107(14):1901–1905.
  • Kim YM, Talanian RV, Billiar TR. Nitric oxide inhibits apoptosis by preventing increases in caspase-3-like activity via two distinct mechanisms. J Biol Chem. 1997 Dec 5;272(49):31138–31148.
  • Malinski T, Bailey F, Zhang ZG, et al. Nitric oxide measured by a porphyrinic microsensor in rat brain after transient middle cerebral artery occlusion. J Cereb Blood Flow Metab. 1993;13:355–358.
  • Huang Z, Huang PL, Panahian N, et al. Effects of cerebral ischemia in mice deficient in neuronal nitric oxide synthase. Science. 1994;265:1883–1885.
  • Kader A, Frazzini VI, Solomon RA, et al. Nitric oxide production during focal cerebral ischemia in rats. Stroke. 1993;24:1709–1716.
  • Niwa M, Inao S, Takayasu M, et al. Time course of expression of three nitric oxide synthase isoforms after transient middle cerebral artery occlusion in rats. Neurol Med Chir (Tokyo). 2001;41:63–72.
  • Morikawa E, Huang Z, Moskowitz MA. L-arginine decreases infarct size caused by middle cerebral arterial occlusion in SHR. Am J Physiol. 1992 Nov;263:H1632–5.
  • Huang Z, Huang PL, Ma J, et al. Enlarged infarcts in endothelial nitric oxide synthase knockout mice are attenuated by nitro-L-arginine. J Cereb Blood Flow Metab. 1996;16:981–987.
  • Lo EH, Hara H, Rogowska J, et al. Temporal correlation mapping analysis of the hemodynamic penumbra in mutant mice deficient in endothelial nitric oxide synthase gene expression. Stroke. 1996;27:1381–1385.
  • Cui X, Chopp M, Zacharek A, et al. Role of endothelial nitric oxide synthase in arteriogenesis after stroke in mice. Neuroscience. 2009;159:744–750.
  • Zhao X, Ross ME, Iadecola C. L-arginine increases ischemic injury in wild-type mice but not in iNOS-deficient mice. Brain Res. 2003;966:308–311.
  • Sehara Y, Hayashi T, Deguchi K, et al. Distribution of inducible nitric oxide synthase and cell proliferation in rat brain after transient middle cerebral artery occlusion. Brain Res. 2006;1093:190–197.
  • Sun Y, Jin K, Childs JT, et al. Neuronal nitric oxide synthase and ischemia-induced neurogenesis. J Cereb Blood Flow Metab. 2005 Apr;25(4):485–492.
  • Willmot M, Gray L, Gibson C, et al. A systematic review of nitric oxide donors and L-arginine in experimental stroke; effects on infarct size and cerebral blood flow. Nitric Oxide-Biol Chem. 2005 May;12(3):141–149.
  • Oppenheimer S, Hachinski V. Complications of acute stroke. Lancet. 1992 Mar;339(8795):721–724.
  • Leonardi-Bee J, Bath PM, Phillips SJ, et al. Blood pressure and clinical outcomes in the International stroke trial. Stroke. 2002 May;33(5):1315–1320.
  • Vemmos KN, Tsivgoulis G, Spengos K, et al. U-shaped relationship between mortality and admission blood pressure in patients with acute stroke. J Intern Med. 2004;255(2):257–265.
  • Sprigg N, Gray LJ, Bath PM, et al. Relationship between outcome and baseline blood pressure and other haemodynamic measures in acute ischaemic stroke: data from the TAIST trial. J Hypertens. 2006 Jul;24(7):1413–1417.
  • Willmot M, Leonardi-Bee J, Bath PM. High blood pressure in acute stroke and subsequent outcome: a systematic review. Hypertension. 2004 Jan;43(1):18–24.
  • Hemphill J, Greenberg S, Anderson C, et al. Guidelines for the management of spontaneous intracerebral hemorrhage. Stroke. 2015;46:2032–2060.
  • Ferlito S, Gallina M, Pitari GM, et al. Nitric oxide plasma levels in patients with chronic and acute cerebrovascular disorders. Panminerva Med. 1998;40:51–54.
  • Rashid PA, Whitehurst A, Lawson N, et al. Plasma nitric oxide (nitrate/nitrite) levels in acute stroke and their relationship with severity and outcome. J Stroke Cerebrovasc Dis. 2003;12(2):82–87.
  • Schultz S, Grady B, Cole F, et al. A role for endothelin and nitric oxide in the pressor response to diaspirin cross-linked hemoglobin. J Lab Clin Med. 1993;122:301–308.
  • Saxena R, Wijnhoud AD, Carton H, et al. Controlled safety study of a hemoglobin-based oxygen carrier, DCLHb, in acute ischemic stroke. Stroke. 1999;30:993–996.
  • Bath P. The effect of nitric oxide-donating vasodilators on monocyte chemotaxis and intracellular cGMP concentration in vitro. Eur J Clin Pharmacol. 1993;45(1):53–58.
  • Bath PMW, Pathansali R, Iddenden R, et al. The effect of transdermal glyceryl trinitrate, a nitric oxide donor, on blood pressure and platelet function in acute stroke. Cerebrovasc Dis. 2001;11:265–272.
  • Rashid P, Weaver C, Leonardi-Bee J, et al. The effects of transdermal glyceryl trinitrate, a nitric oxide donor, on blood pressure, cerebral and cardiac hemodynamics, and plasma nitric oxide levels in acute stroke. J Stroke Cerebrovasc Dis. 2003;12(3):143–151.
  • Willmot M, Ghadami A, Whysall B, et al. Transdermal glyceryl trinitrate lowers blood pressure and maintains cerebral blood flow in recent stroke. Hypertension. 2006;47:1209–1215.
  • Gray LJ, Sprigg N, Rashid PA, et al. Effect of nitric oxide donors on blood pressure and pulse pressure in acute and sub-actue stroke. J Stroke Cerebrovascular Dis. 2006;15(6):245–249.
  • Geeganage CM, Bath AJ, Bath PM. The effect of transdermal glyceryl trinitrate on 24 h ambulatory blood pressure in acute/subacute stroke. Int J Stroke. 2011 Aug;6(4):290–294.
  • Butterworth RJ, Cluckie A, Jackson SH, et al. Pathophysiological assessment of nitric oxide (given as sodium nitroprusside) in acute ischaemic stroke. Cerebrovasc Dis. 1998 May-Jun;8(3):158–165.
  • Bath P, Woodhouse L, Scutt P, et al. Efficacy of nitric oxide, with or without continuing antihypertensive treatment, for management of high blood pressure in acute stroke (ENOS): a partial-factorial randomised controlled trial. Lancet. 2015 Feb 13;385(9968):617–628.
  • Appleton JP, Woodhouse LJ, Bereczki D, et al. Effect of glyceryl trinitrate on hemodynamics in acute stroke. Stroke. 2019 Feb 01;50(2):405–412.
  • Woodhouse L, Scutt P, Krishnan K, et al. Effect of hyperacute administration (within 6 hours) of transdermal glyceryl trinitrate, a nitric oxide donor, on outcome after stroke: subgroup analysis of the Efficacy of Nitric Oxide in Stroke (ENOS) trial. Stroke. 2015;46:3194–3201.
  • Ankolekar S, Fuller M, Cross I, et al. Feasibility of an ambulance-based stroke trial, and safety of glyceryl trinitrate in ultra-acute stroke: the rapid intervention with glyceryl trinitrate in Hypertensive stroke trial (RIGHT, ISRCTN66434824). Stroke. 2013 Nov;44(11):3120–3128.
  • Bath PM, Woodhouse L, Krishnan K, et al. Effect of treatment delay, stroke type, and thrombolysis on the effect of glyceryl trinitrate, a nitric oxide donor, on outcome after acute stroke: a systematic review and meta-analysis of individual patient from randomised trials. Stroke Res Treat. 2016;9706720:12.
  • Bath PM, Krishnan K, Appleton JP. Nitric oxide donors (nitrates), L-arginine, or nitric oxide synthase inhibitors for acute stroke. Cochrane Database Syst Rev. 2017 Apr 21;4:CD000398.
  • Krishnan K, Scutt P, Woodhouse L, et al. Glyceryl trinitrate for acute intracerebral haemorrhage: results from the Efficacy of Nitric Oxide in Stroke (ENOS) trial, a subgroup analysis. Stroke. 2016;47(1):44–52.
  • Appleton JP, Woodhouse LJ, Belcher A, et al. It is safe to use transdermal glyceryl trinitrate to lower blood pressure in patients with acute ischaemic stroke with carotid stenosis. Stroke Vasc Neurol. 2019;4(1):28.
  • Billington CK, Appleton JP, Berge E, et al. Impact of hydration status on haemodynamics, effects of acute blood pressure-lowering treatment, and prognosis after stroke. Br J Clin Pharmacol. 2018 Dec 01;84(12):2914–2922.
  • Bath PM, Scutt P, Anderson CS, et al. Prehospital transdermal glyceryl trinitrate in patients with ultra-acute presumed stroke (RIGHT-2): an ambulance-based, randomised, sham-controlled, blinded, phase 3 trial. Lancet. 2019;393:1009–1020. .
  • Sandercock PAG, Counsell C, Tseng M-C, et al. Oral antiplatelet therapy for acute ischaemic stroke. Cochrane Database Syst Rev. 2014;3:CD000029.
  • Emberson J, Lees K, Lyden P, et al. Effect of treatment delay, age and stroke severity on the effects of intravenous thrombolysis with alteplase for acute ischaemic stroke: a meta-analysis of individual patient data from randomised trials. Lancet. 2014 Nov 29;384(9958):1929–1935.
  • Goyal M, Menon BK, van Zwam WH, et al. Endovascular thrombectomy after large-vessel ischaemic stroke: a meta-analysis of individual patient data from five randomised trials. Lancet. 2016;397(10029):1723–1731.
  • Minhas J, Wang X, Chalmers J, et al. The enhanced control of hypertension and thrombolysis stroke study (ENCHANTED) blood pressure (BP) arm: comparative effects of intensive- versus standard-BP lowering treatment in large-vessel occlusion. Eur Stroke J. 2019;4(1S):35.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.